Indian Company Master Data Made Simple
Aspira Pathlab & Diagnostics Limited
Profile data last updated: 20/12/2024
Founded in 1973, Aspira Pathlab & Diagnostics Limited has been operating for more than 52 years. Aspira Pathlab & Diagnostics Limited holds the CIN L85100MH1973PLC289209 and registration number 289209. It belongs to the classification of company limited by shares as per MCA records. The company’s authorized capital value is ₹35.00 crore. The company’s paid-up capital is ₹15.79 crore.
Aspira Pathlab & Diagnostics Limited primarily operates in health and social work. Its registered office is located in Mumbai. Its official registered office is situated at Flat No.2 , R.d. Shah Bldg,shraddhanand Road Opp. Ghatkopar Railway Station, Ghatkopa, R (west), Mumbai City, Mumbai, Maharashtra, India, 400086. The company maintains an active registration. The company may be contacted through its official email: [email protected]. The leadership team includes Pankaj Jashwant Shah (CEO) and Balkrishna Subhash Talawadekar (CFO).
Company Overview
- CIN
- Date of Incorporation
- 03/07/1973
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹35,00,00,000.00
- Paid up Capital
- ₹15,79,30,000.00
- Activity
- Health And Social Work
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹292.27L | ₹249.53L | ₹300.65L | ₹355.72L | ₹0.00L |
| Accumulated Depreciation | -₹1,142.81L | -₹1,006.62L | -₹855.57L | -₹703.30L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹529.51L | ₹456.63L | ₹459.13L | ₹534.59L | ₹0.00L |
| Tangible Book Value | ₹457.07L | ₹254.37L | ₹512.49L | ₹511.04L | ₹0.00L |
| Long Term Debt | ₹120.64L | ₹107.72L | ₹96.18L | ₹0.00L | ₹0.00L |
| Long Term Provisions | ₹55.36L | ₹41.14L | ₹36.79L | ₹28.25L | ₹0.00L |
| Goodwill | ₹265.18L | ₹265.18L | ₹265.18L | ₹265.18L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹82.68L | ₹69.82L | ₹67.48L | ₹64.72L | ₹0.00L |
| Machinery Furniture Equipment | ₹111.07L | ₹106.31L | ₹103.58L | ₹97.52L | ₹0.00L |
| Total Assets | ₹1,746.15L | ₹1,470.96L | ₹1,734.17L | ₹1,813.53L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,216.64L | ₹1,014.33L | ₹1,275.04L | ₹1,278.94L | ₹0.00L |
| Gross PPE | ₹1,528.95L | ₹1,418.35L | ₹1,386.86L | ₹1,385.72L | ₹0.00L |
| Common Stock | ₹1,029.30L | ₹1,029.30L | ₹1,029.30L | ₹1,029.30L | ₹0.00L |
| Total Capitalization | ₹1,216.64L | ₹1,014.33L | ₹1,275.04L | ₹1,278.94L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹266.59L | ₹266.98L | ₹269.57L | ₹274.92L | ₹0.00L |
| Total Debt | ₹198.96L | ₹170.49L | ₹235.17L | ₹306.31L | ₹0.00L |
| Other Equity Interest | ₹187.34L | -₹14.97L | ₹245.74L | ₹249.65L | ₹0.00L |
| Other Non Current Liabilities | -₹0.01L | ₹0.00L | -₹0.01L | ₹0.01L | ₹0.01L |
| Capital Stock | ₹1,522.28L | ₹1,522.28L | ₹1,522.28L | ₹1,522.28L | ₹0.00L |
| Additional Paid In Capital | ₹903.01L | ₹903.01L | ₹903.01L | ₹903.01L | ₹0.00L |
| Total Non Current Assets | ₹1,209.71L | ₹1,035.46L | ₹1,148.53L | ₹1,099.11L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹214.38L | ₹138.29L | ₹234.91L | ₹164.36L | ₹0.00L |
| Invested Capital | ₹723.66L | ₹521.35L | ₹782.06L | ₹785.96L | ₹0.00L |
| Net Tangible Assets | ₹950.05L | ₹747.35L | ₹1,005.47L | ₹1,004.02L | ₹0.00L |
| Cash And Cash Equivalents | ₹175.22L | ₹80.23L | ₹56.63L | ₹135.43L | ₹0.00L |
| Prepaid Assets | ₹34.58L | ₹27.20L | ₹74.68L | ₹60.50L | ₹0.00L |
| Stockholders Equity | ₹1,216.64L | ₹1,014.33L | ₹1,275.04L | ₹1,278.94L | ₹0.00L |
| Other Short Term Investments | ₹39.16L | ₹58.06L | ₹178.28L | ₹28.93L | ₹0.00L |
| Share Issued | ₹102.93L | ₹102.93L | ₹102.93L | ₹102.93L | ₹0.00L |
| Current Assets | ₹536.45L | ₹435.51L | ₹585.64L | ₹714.42L | ₹0.00L |
| Working Capital | ₹299.21L | ₹228.41L | ₹427.16L | ₹535.55L | ₹0.00L |
| Current Debt | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Ordinary Shares Number | ₹102.93L | ₹102.93L | ₹102.93L | ₹102.93L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹116.28L | ₹100.67L | ₹167.69L | ₹241.59L | ₹0.00L |
| Current Liabilities | ₹237.24L | ₹207.10L | ₹158.48L | ₹178.87L | ₹0.00L |
| Retained Earnings | -₹1,208.65L | -₹1,410.96L | -₹1,150.25L | -₹1,146.35L | ₹0.00L |
| Net PPE | ₹386.14L | ₹411.73L | ₹531.29L | ₹682.42L | ₹0.00L |
| Other Non Current Assets | ₹0.01L | ₹0.01L | ₹0.01L | -₹0.01L | ₹0.00L |
| Common Stock Equity | ₹723.66L | ₹521.35L | ₹782.06L | ₹785.96L | ₹0.00L |
| Other Intangible Assets | ₹1.41L | ₹1.80L | ₹4.39L | ₹9.74L | ₹0.00L |
| Inventory | ₹51.13L | ₹44.72L | ₹40.44L | ₹40.45L | ₹0.00L |
| Other Properties | ₹666.08L | ₹670.39L | ₹647.14L | ₹641.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Changes In Cash | ₹94.86L | ₹23.72L | -₹78.77L | ₹16.67L | ₹0.00L |
| Financing Cash Flow | -₹99.42L | -₹95.41L | -₹93.50L | -₹135.20L | ₹0.00L |
| Investing Cash Flow | ₹11.57L | ₹13.78L | ₹15.93L | -₹51.23L | ₹0.00L |
| Free Cash Flow | ₹148.28L | ₹79.03L | -₹14.83L | ₹142.40L | ₹0.00L |
| End Cash Position | ₹175.24L | ₹80.38L | ₹56.67L | ₹135.44L | ₹0.00L |
| Capital Expenditure | -₹34.43L | -₹26.32L | -₹13.63L | -₹60.70L | ₹0.00L |
| Beginning Cash Position | ₹80.38L | ₹56.66L | ₹135.44L | ₹118.77L | ₹0.00L |
| Operating Cash Flow | ₹182.71L | ₹105.35L | -₹1.20L | ₹203.10L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Rent Expense Supplemental | ₹3.63L | ₹4.90L | ₹24.99L | ₹3.48L |
| Net Income From Continuing Operation Net Minority Interest | ₹202.26L | -₹267.22L | -₹8.87L | ₹445.94L |
| Basic EPS | ₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| EBITDA | ₹382.17L | -₹81.63L | ₹186.37L | ₹640.33L |
| Total Unusual Items | -₹4.21L | -₹0.63L | ₹0.82L | -₹32.97L |
| Operating Revenue | ₹2,199.90L | ₹1,320.49L | ₹1,445.69L | ₹1,954.19L |
| Total Expenses | ₹1,992.47L | ₹1,590.76L | ₹1,444.50L | ₹1,447.48L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.21L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹4.21L | -₹0.63L | ₹0.82L | -₹32.97L |
| Interest Income Non Operating | ₹36.90L | ₹39.94L | ₹29.08L | ₹9.48L |
| Interest Income | ₹36.90L | ₹39.94L | ₹29.08L | ₹9.48L |
| Interest Expense Non Operating | ₹30.53L | ₹31.71L | ₹36.68L | ₹30.82L |
| Net Income From Continuing And Discontinued Operation | ₹202.26L | -₹267.22L | -₹8.87L | ₹445.94L |
| General And Administrative Expense | ₹176.20L | ₹159.38L | ₹136.69L | ₹104.91L |
| Reconciled Depreciation | ₹149.38L | ₹153.88L | ₹158.56L | ₹163.57L |
| Net Income Continuous Operations | ₹202.26L | -₹267.22L | -₹8.87L | ₹445.94L |
| Reconciled Cost Of Revenue | ₹471.63L | ₹339.09L | ₹306.98L | ₹450.37L |
| Operating Income | ₹207.43L | -₹270.27L | ₹1.19L | ₹506.71L |
| Net Income | ₹202.26L | -₹267.22L | -₹8.87L | ₹445.94L |
| Diluted Average Shares | ₹102.93L | ₹102.93L | ₹102.93L | ₹102.93L |
| Selling And Marketing Expense | ₹23.32L | ₹26.55L | ₹26.56L | ₹16.54L |
| Normalized Income | ₹206.47L | -₹266.59L | -₹9.48L | ₹478.91L |
| Total Other Finance Cost | ₹4.21L | ₹5.06L | ₹5.04L | ₹6.45L |
| Net Non Operating Interest Income Expense | ₹2.16L | ₹3.17L | -₹12.64L | -₹27.79L |
| Gross Profit | ₹1,728.27L | ₹981.40L | ₹1,138.71L | ₹1,503.82L |
| EBIT | ₹232.79L | -₹235.51L | ₹27.81L | ₹476.76L |
| Cost Of Revenue | ₹471.63L | ₹339.09L | ₹306.98L | ₹450.37L |
| Diluted NIAvailto Com Stockholders | ₹202.26L | -₹267.22L | -₹8.87L | ₹445.94L |
| Net Interest Income | ₹2.16L | ₹3.17L | -₹12.64L | -₹27.79L |
| Operating Expense | ₹1,520.84L | ₹1,251.67L | ₹1,137.52L | ₹997.11L |
| Normalized EBITDA | ₹386.38L | -₹81.00L | ₹185.55L | ₹673.30L |
| Net Income Common Stockholders | ₹202.26L | -₹267.22L | -₹8.87L | ₹445.94L |
| Pretax Income | ₹202.26L | -₹267.22L | -₹8.87L | ₹445.94L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Selling General And Administration | ₹199.52L | ₹185.93L | ₹163.25L | ₹121.45L |
| Total Revenue | ₹2,199.90L | ₹1,320.49L | ₹1,445.69L | ₹1,954.19L |
| Other Operating Expenses | ₹435.69L | ₹287.17L | ₹231.44L | ₹206.66L |
| Diluted EPS | ₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| Interest Expense | ₹30.53L | ₹31.71L | ₹36.68L | ₹30.82L |
| Basic Average Shares | ₹102.93L | ₹102.93L | ₹102.93L | ₹102.93L |
| Net Income Including Noncontrolling Interests | ₹202.26L | -₹267.22L | -₹8.87L | ₹445.94L |
| Tax Provision | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 28/09/2015 | Mangala Radhakrishna Prabhu | 06450659 | Director | View other directorships |
| 01/08/2016 | Pankaj Jashwant Shah | 02836324 | Managing Director | View other directorships |
| 01/02/2017 | Avinash Chander Mahajan | 00041661 | Director | View other directorships |
| 27/10/2018 | Haseeb Ahmad Drabu | 00489888 | Director | View other directorships |
| 13/06/2020 | Pankaj Jashwant Shah | *****4891R | CEO | |
| 29/08/2020 | Nikunj Velji Mange | 08489442 | Director | View other directorships |
| 13/02/2021 | Balkrishna Subhash Talawadekar | *****8835R | CFO | |
| 12/08/2023 | Manas Rajendra Mengar | 10218206 | Director | View other directorships |
| 12/08/2023 | Krupali Kirti Kumar Shah | *****5349J | Company Secretary |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 24/11/2024 | Form MGT-7-24112024 | - |
| 24/11/2024 | Form MGT-7-24112024_signed | - |
| 23/10/2024 | Form AOC-4(XBRL)-23102024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Aatmaj Healthcare Limited | L85100GJ2014PLC079062 | Jupiterhospital,opp.icaibhavan,sunpharmaataladraroad,,vadodara,vadodara,gujarat,390012-india |
| Birla Pacific Medspa Limited | L85100MH2008PLC184689 | Dalamal House, 1st Floor Nariman Point, Mumbai City, Mumbai, Maharashtra, India, 400021 |
| Jupiter Life Line Hospitals Limited | L85100MH2002PLC137908 | - |
| Tejnaksh Healthcare Limited | L85100MH2008PLC179034 | A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai City, Mumbai, Maharashtra, India, 400079 |
| Tiaan Consumer Limited | L85100GJ1992PLC017397 | 405, Patel Ashwamegh Complex Jetalpur Road, Near Dairy Den Circle, Sa, Yajigunj, Vadodara, Vadodara, Gujarat, India, 390005 |
Address
Flat No.2 , R.d. Shah Bldg,shraddhanand Road Opp. Ghatkopar Railway Station, Ghatkopa, R (west), Mumbai City, Mumbai, Maharashtra, India, 400086
Frequently Asked Questions
What is the incorporation date of Aspira Pathlab & Diagnostics Limited?
The incorporation date of Aspira Pathlab & Diagnostics Limited is 03/07/1973.
What is the authorized share capital and paid-up capital of Aspira Pathlab & Diagnostics Limited?
The authorized share capital of Aspira Pathlab & Diagnostics Limited is ₹35,00,00,000.00. The paid-up capital is ₹15,79,30,000.00.
Who are the current board members & directors of Aspira Pathlab & Diagnostics Limited?
The current board member of Aspira Pathlab & Diagnostics Limited are:
- Pankaj Jashwant Shah
- Pankaj Jashwant Shah
- Haseeb Ahmad Drabu
- Avinash Chander Mahajan
- Nikunj Velji Mange
- Mangala Radhakrishna Prabhu
- Manas Rajendra Mengar
What is the registered address of Aspira Pathlab & Diagnostics Limited?
The registered address of Aspira Pathlab & Diagnostics Limited is Flat No.2 , R.d. Shah Bldg,shraddhanand Road Opp. Ghatkopar Railway Station, Ghatkopa, R (west), Mumbai City, Mumbai, Maharashtra, India, 400086.
What is the Corporate Identification Number of Aspira Pathlab & Diagnostics Limited?
The Corporate Identification Number of Aspira Pathlab & Diagnostics Limited is L85100MH1973PLC289209.